Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | allantoin | 204 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | allantoin | 204 | drug-path |
| Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | todralazine | 6914273 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | todralazine | 6914273 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | todralazine | 6914273 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | todralazine | 6914273 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | todralazine | 6914273 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | todralazine | 6914273 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | todralazine | 6914273 | drug-path |
| Melanogenesis | R-HSA-5662702 | map04916 | dexpanthenol | 131204 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | dexpanthenol | 131204 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | dexpanthenol | 131204 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | dexpanthenol | 131204 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | dexpanthenol | 131204 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | dexpanthenol | 131204 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dexpanthenol | 131204 | drug-path |
| Asthma | R-HSA-444620 | map05310 | dexpanthenol | 131204 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | dexpanthenol | 131204 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | dexpanthenol | 131204 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | dexpanthenol | 131204 | drug-path |